Medical devices, healthcare technology and the business of care
510(k) clearance · K262213

Power Mobility Scooter (MA03)

Nanjing Mijo Technology Co., Ltd. · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONK262213

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-29 for Power Mobility Scooter (MA03), submitted by Nanjing Mijo Technology Co., Ltd. under 510(k) number K262213. The device falls under regulation 890.3800, product code INI, with the classification name Vehicle, Motorized 3-Wheeled, and Physical Medicine as both medical specialty and review panel. The application was received 06/30/2026 as a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. SESE denotes clearance to market, not PMA approval.

The available summary excerpt describes the subject device as using a 24 V, 180 W motor, one 24 V, 10.4 Ah lithium-ion battery and an off-board charger, with anti-tip devices and a stated theoretical driving range of 10.1 km versus 16.3 km for the predicate device. The excerpt also references an 8° figure whose meaning is not established in the retrieved text. The predicate device is not identified in the available material, and no clinical or performance conclusions are drawn here; the full decision document should be consulted for scope and any conditions.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Sep 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262213
Regulatory pathway
510(k) premarket notification
Product code
INI
Decision code
SESE
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Vehicle, Motorized 3-Wheeled.

Product code
INI
FDA device class
2

FDA decision timeline

  1. K262213 received

    Application receipt date recorded by FDA.

  2. K262213 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code INI

Product / regulatory recordCompanyPathwayDecision dateSource
Zhejiang Kailang Technology Co., Ltd.510(k) clearanceSep 29, 2026FDA
Anhui JBH Medical Apparatus Co., Ltd.510(k) clearanceSep 24, 2026FDA
Anhui JBH Medical Apparatus Co., Ltd.510(k) clearanceSep 19, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Nanjing Mijo Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Nanjing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records